Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment

Keyphrases

• Clinical Application 100%
• Growth Factor Binding 100%
• Binding Protein 100%
• TIMP-2 100%
• Injury Risk Assessment 100%
• Urinary Biomarkers 100%
• Insulin-like 100%
• Acute Kidney Injury 100%
• Serum Creatinine Level 28%
• Kidney Function 14%
• Moderate to Severe 14%
• Critically Ill 14%
• U.S. Food 14%
• Early Detection 14%
• Risk Stratification 14%
• Urine Concentration 14%
• Time-resolved Detection 14%
• Long-term Consequences 14%
• Serious Complications 14%
• Early Risk 14%
• Novel Object Recognition 14%
• Critically Ill Patients 14%
• Biological Action 14%
• Early Recognition 14%
• Early Diagnosis 14%
• Reduced Kidney Function 14%
• Cell Cycle Arrest Biomarkers 14%
• Clinical Interpretation 14%
• Kidney Injury 14%
• Clinical Setting 14%
• Diagnosis Management 14%
• Clinical Prognosis 14%
• Clinical Investigation 14%
• Severe Acute Kidney Injury 14%
• Clinical Limitations 14%
• Glomerular Filtration 14%

Medicine and Dentistry

• Biological Marker 100%
• Somatomedin Binding Protein 2 100%
• Acute Kidney Injury 100%
• Metalloprotease Inhibitor 100%
• Kidney Function 25%
• Creatinine 25%
• Glomerulus Filtration 12%
• Risk Stratification 12%
• Early Diagnosis 12%
• Cell Cycle Arrest 12%
• Kidney Concentrating Capacity 12%
• Somatomedin Binding Protein 12%
• Tissue Inhibitor of Metalloproteinase 2 12%
• Kidney Injury 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Acute Kidney Failure 100%
• Tissue Inhibitor of Metalloproteinase 100%
• Somatomedin Binding Protein 2 100%
• Creatinine 25%
• Somatomedin Binding Protein 12%
• Tissue Inhibitor of Metalloproteinase 2 12%
• Kidney Injury 12%